Re: Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome Reply

被引：0
|
作者：
Lainas, T. G. [1 ]
Kolibianakis, E. M. [2 ]
机构：
[1] Eugonia Unit Assisted Reprod, Athens, Greece
[2] Aristotle Univ Thessaloniki, Human Reprod Unit, Dept Obstet & Gynecol 1, Papageorgiou Gen Hosp,Med Sch, GR-54006 Thessaloniki, Greece
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2015年 / 122卷 / 04期
关键词：
D O I：
10.1111/1471-0528.13068
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：585 / 586
页数：2
相关论文
共 50 条
  • [21] Outcomes from ovarian hyperstimulation following the sole administration of gonadotrophin-releasing hormone agonist in the context of in vitro fertilization: report of two cases and review of the literature
    Pinto, Evelin
    Pinelo, Sueli
    Osorio, Marta
    Ferreira, Carla
    Serra, Helena
    Pires, Ilda
    Barbosa, Antonio
    Figueiredo, Helena
    Felgueira, Eduarda
    Tavares, Angelina
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (07) : 545 - 548
  • [22] Variations in serum vascular endothelial growth factor binding profiles and the development of ovarian hyperstimulation syndrome
    McElhinney, B
    Ardill, J
    Caldwell, C
    Lloyd, F
    McClure, N
    FERTILITY AND STERILITY, 2002, 78 (02) : 286 - 290
  • [23] Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception
    Mathur, R
    Hayman, G
    Bansal, A
    Jenkins, J
    FERTILITY AND STERILITY, 2002, 78 (06) : 1154 - 1158
  • [24] Follicular fluid levels of vascular endothelial growth factor -: Are they predictive markers for ovarian hyperstimulation syndrome
    Geva, E
    Amit, A
    Lessing, JB
    Lerner-Geva, L
    Daniel, Y
    Yovel, I
    Azem, F
    Barak, V
    JOURNAL OF REPRODUCTIVE MEDICINE, 1999, 44 (02) : 91 - 96
  • [25] Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program
    Artini, PG
    Fasciani, A
    Monti, M
    Luisi, S
    D'Ambrogio, G
    Genazzani, AR
    FERTILITY AND STERILITY, 1998, 70 (03) : 560 - 564
  • [26] Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome
    Chen, CD
    Wu, MY
    Chen, HF
    Chen, SU
    Ho, HN
    Yang, YS
    HUMAN REPRODUCTION, 2000, 15 (01) : 66 - 71
  • [27] Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome
    D'Ambrogio, G
    Fasciani, A
    Monti, M
    Cattani, R
    Genazzani, AR
    Artini, PG
    GYNECOLOGICAL ENDOCRINOLOGY, 1999, 13 (05) : 311 - 315
  • [28] Circulating vascular endothelial growth factor (VEGF) levels in nonhuman primates and women: species differences and relevance to ovarian hyperstimulation syndrome
    Molskness, TA
    Patton, PE
    Martinez-Chequer, JC
    Klementiev, BN
    Stouffer, RL
    FERTILITY AND STERILITY, 2001, 76 (03) : S90 - S91
  • [29] Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome
    TONG XiaomeiZHANG SongyingSONG TaoXU WeihaiLIN XiaonaSHU Jing and LIU Liu Department of Reproductive MedicineSir Run Run Shaw HospitalAffiliated with School of MedicineZhejiang University HangzhouZhejiang China
    中华医学杂志（英文版）, 2008, (23) : 2434 - 2439
  • [30] Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome
    Tong Xiao-mei
    Zhang Song-ying
    Song Tao
    Xu Wei-hai
    Lin Xiao-na
    Shu Jing
    Liu Liu
    CHINESE MEDICAL JOURNAL, 2008, 121 (23) : 2434 - 2439
12345